DOI:​10.1006/GYNO.1994.1253
Corpus ID: 38692727
Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability.
M. Préfontaine, A. Gelfand, +1 author J. L. Powell
Published 1994
Medicine
Gynecologic oncology
We evaluated the accuracy and interobserver variability of intraoperative tumor measurements in ovarian cancer. Thirty-four obstetrician-gynecologists, 26 gynecologic oncologists, and 12 residents… Expand
View On PubMed
Doi.Org
Share This Paper
43 Citations
Highly Influential Citations
1
Background Citations
14
Methods Citations
3
Results Citations
1
Topics from this paper
Neoplasms
ovarian neoplasm
Antineoplastic Protocols
Malignant neoplasm of ovary
Estimated
Dental Plaque
Protocols documentation
43 Citations
The Value of Postoperative/Preadjuvant Chemotherapy Computed Tomography in the Management of Patients With Ovarian Cancer
E. Sala, L. Mannelli, +5 authors R. Crawford
Medicine
International Journal of Gynecologic Cancer
2010
TLDR
There was only 59% correlation between the surgical assessment and postoperative CT findings of residual disease in patients reported to have undergone optimal surgery, and stage and residual disease as assessed by the surgeon were significant prognostic factors for overall survival. Expand
14 Citations
Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer?
D. Lorusso, I. Sarno, +5 authors F. Raspagliesi
Medicine
Oncology

2014
TLDR
Evidence of the disease using postoperativeCT was associated with a significant decrease in PFS in patients who underwent optimal primary cytoreduction and RT status as evaluated with early postoperative CT may have an important role in prognostic assessment. Expand
6 Citations
The myth of measurable disease in ovarian cancer.
M. Markman
Medicine
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2003
TLDR
The Gynecologic Cancer Intergroup, a highly regarded international consortium of clinical investigators, has officially modified its criteria for the evaluation of efficacy in ovarian cancer randomized trials to include well-characterized changes in a validated serum tumor marker (CA-125) as an acceptable objective endpoint for progression-free survival in these studies. Expand
34 Citations
Referral patterns for suspected ovarian cancer: a survey of practicing gynecologists
M. Préfontaine, A. Gruslin
Medicine
International Journal of Gynecologic Cancer
1995
TLDR
Gynecologists seeing fewer patients with suspected ovarian cancers, in a teaching vs community hospital, in full-time university vs private practice and working in specific geographical areas, referred more to an oncologist for the primary surgery. Expand
6 Citations
Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery
S. Hosono, H. Kajiyama, +6 authors F. Kikkawa
Medicine
International Journal of Clinical Oncology
2011
TLDR
Although primary maximal cytoreduction is essential to improving OS in advanced ovarian cancer, the findings suggest the management of patients with suboptimal residual tumor should take into account differences between histological subtypes. Expand
9 Citations
PDF
A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
N. Coburn, Emily M. Clarke-Pearson, M. Chung, C. Law, J. Fulton, B. Cady
MedicineAmerican journal of surgery
2006
TLDR
A more rational T category for use in tumor-node-metastasis staging is presented to reflect the much smaller invasive breast cancers encountered by screening and to account for the dimension recording bias of pathologists. Expand
4 Citations
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
Y. Lakhman, O. Akin, +7 authors H. Hricak
MedicineAJR. American journal of roentgenology
2012
TLDR
It was showed that residual disease larger than 1 cm was present on early postoperative CT in almost half of the patients deemed to have optimally debulked disease at primary cytoreduction, associated with significant decreases in both progression-free and overall survival. Expand
16 Citations
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
D. Chi, P. Ramirez, +13 authors R. Barakat
Medicine
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2007
TLDR
There was only a 52% correlation between surgeons' assessments and postoperative CT scan evaluations of RD in patients reported to have undergone optimal cytoreduction, and further study is required to determine whether this lack of correlation is due to rapid interval tumor regrowth, RD underestimated by the surgeons, and/or overestimated by the radiologists. Expand
58 Citations
What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
S. Eisenkop, N. Spirtos
MedicineGynecologic oncology
2001
TLDR
A range of surgical objectives, strategies, procedures used, and outcomes exists among gynecologic oncologists and confirmation of the efficacy of cytoreductive surgery may cultivate a consensus about the most appropriate therapeutic objective and strategy for advanced ovarian cancer. Expand
183 Citations
A critique of surgical cytoreduction in advanced ovarian cancer.
A. Covens
MedicineGynecologic oncology
2000
TLDR
Biases and ethical issues based upon the data cited in this paper have and will continue to hamper the ability to fully elaborate the benefits of surgery with respect to survival and quality of life. Expand
174 Citations
...
1
2
3
4
...
Related Papers
Show More
2/0
Abstract
Topics
43 Citations
Related Papers
Stay Connected With Semantic Scholar
What Is Semantic Scholar?
Semantic Scholar is a free, AI-powered research tool for scientific literature, based at the Allen Institute for AI.
Learn More
About
About Us
Publishers
Beta Program
Contact
Research
Team
Datasets
Open Corpus
Supp.ai
Resources
Librarians
Tutorials
FAQ
API
Proudly built by AI2
Terms of ServicePrivacy Policy
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE